We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 76
Most popular |Most recent


Anti-Corruption Quarterly - 3rd quarter 2017

USA, United Kingdom - November 7 2017 The healthcare industry is no stranger to Department of Justice (DOJ) scrutiny. DOJ prosecutors have aggressively pursued improper billing practices...

Joseph B. Tompkins Jr., Zhengyu Tang, David L. Anderson, Timothy J. Treanor, Dorothy Cory-Wright, Henry H. Ding, Kristin Graham Koehler, Karen A. Popp, Leslie A. Shubert.


China Food and Drug Administration Announces Penalties for Clinical Trial Data Integrity Violations

China - May 31 2017 On May 24, 2017, the China Food and Drug Administration (CFDA) issued its 2017 Circular No. 63 (the Circular), setting out penalties for clinical...

Lei Li.


China Food and Drug Administration Simplifies Approval Procedures for Drugs and Medical Devices

China - April 11 2017 The China Food and Drug Administration (CFDA) published two announcements on April 5 and 6, 2017, delegating some of its approval authority for drugs...

Lei Li.


China Proposes Significant Changes to Its Import Drug Registration System

China - March 20 2017 On March 17, the China Food and Drug Administration (CFDA) published a draft Decision for Adjusting the Administrative Regime for Import......

Lei Li.


The China Food and Drug Administration’s 2017 Reform Efforts Highlighted Seven Priorities

China - March 1 2017 On February 27, in a press conference held by China's State Council, Mr. Bi Jingquan, the head of the China Food and Drug Administration (CFDA)...

Lei Li.